Biotest
Dr. Carolin Schmidt currently serves as the Manager of Clinical Strategy & Development at Biotest AG since January 2023. Previously, Dr. Schmidt held the position of Senior Project Coordinator at ClinTriCare GmbH from May 2021 to January 2023, and was a Postdoctoral Researcher at Biotest AG from February 2017 to December 2020, following a Doctoral research phase. Dr. Schmidt also contributed to the Paul-Ehrlich-Institut during the completion of a Master's thesis in 2016. Academically, Dr. Schmidt earned a Master of Science in Cell Biology and Physiology from Goethe University Frankfurt in 2016, after obtaining a Bachelor of Science in Biowissenschaften from the same institution in 2014.
This person is not in any offices
Biotest
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.